Since 2017, when the Constitutional Court issued a groundbreaking ruling overturning previous regulations on reimbursable medical devices prescribed by voucher, experts have been discussing the urgent need for a new legislative framework governing the inclusion of separately billed material (ZUM) in public health insurance reimbursements. In the interim, VZP has developed a relatively transparent methodology designed to temporarily bridge the gaps in the inadequate legal fram

Subcommittee on Drug Policy, Medical Equipment, and Medical Devices hosted a roundtable discussion on VAT rates for IVD.

March 2 is approaching, bringing with it the obligation to review and confirm their data in the ISZP system.

The EU is introducing new battery requirements under Regulation (EU) 2023/1542, including those used in medical devices.

An amendment to the Prices Act came into force, which fundamentally changes the procedural rules of the price regulation of MDs.